The Hidden Risk: How Weight-Loss Drugs May Fuel Eating Disorders
As prescriptions for GLP-1 receptor agonists soar globally, clinicians express growing concern over their potential impact on vulnerable patients struggling with disordered eating.
Latest stories, in-depth analysis & breaking updates
As prescriptions for GLP-1 receptor agonists soar globally, clinicians express growing concern over their potential impact on vulnerable patients struggling with disordered eating.
Researchers are launching a major clinical initiative to validate biological markers for major depressive disorder, potentially ending decades of subjective psychiatric diagnosis.